Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Lees

Showing results (81-90 of 445) with videos related to

Pageof 45
Sort By:
Internal Medicine Journal|April 22, 2008
How do patients with parkinsonism present? A clinicopathological studyD R Williams, A J Lees
Advances in Neurology|January 1, 1983
Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's diseaseG M Stern, A J Lees
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1988
Late progression of post-encephalitic Parkinson's syndromeD B Calne, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1981
Sustained bromocriptine therapy in previously untreated patients with Parkinson's diseaseA J Lees, G M Stern
Neurology|July 1, 1986
The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)E R Maher, A J Lees
Neurology|June 1, 1985
Methysergide in progressive supranuclear palsyA S Duncombe, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1994
Micrographia associated with a parietal lobe lesion in multiple sclerosisN J Scolding, A J Lees
Hospital Medicine (London, England : 1998)|March 9, 2000
Use of apomorphine in Parkinson's diseaseJ D O'Sullivan, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1995
Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin AG L Sheean, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1991
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's diseaseW R Gibb, A J Lees
Pageof 45

Showing results (81-90 of 445) with videos related to

Sort By:
Pageof 45
Internal Medicine Journal|April 22, 2008
How do patients with parkinsonism present? A clinicopathological studyD R Williams, A J Lees
Advances in Neurology|January 1, 1983
Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's diseaseG M Stern, A J Lees
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1988
Late progression of post-encephalitic Parkinson's syndromeD B Calne, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1981
Sustained bromocriptine therapy in previously untreated patients with Parkinson's diseaseA J Lees, G M Stern
Neurology|July 1, 1986
The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)E R Maher, A J Lees
Neurology|June 1, 1985
Methysergide in progressive supranuclear palsyA S Duncombe, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1994
Micrographia associated with a parietal lobe lesion in multiple sclerosisN J Scolding, A J Lees
Hospital Medicine (London, England : 1998)|March 9, 2000
Use of apomorphine in Parkinson's diseaseJ D O'Sullivan, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1995
Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin AG L Sheean, A J Lees
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1991
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's diseaseW R Gibb, A J Lees
Pageof 45